Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/28/2012 | WO2012059925A9 Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof |
06/28/2012 | WO2012051282A3 Piwil2-like (pl2l) proteins-targeted cancer diagnosis and therapy |
06/28/2012 | WO2012045063A3 Flavivirus domain iii vaccine |
06/28/2012 | WO2012042540A9 Anticancer agent |
06/28/2012 | US20120167259 Novel bacillus thuringiensis gene with lepidopteran activity |
06/28/2012 | US20120165508 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins |
06/28/2012 | US20120165507 Mutant proteins and methods for producing them |
06/28/2012 | US20120165267 Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF |
06/28/2012 | US20120165230 Biologically produced cyclic affinity tags |
06/28/2012 | US20120165228 Evolving new molecular function |
06/28/2012 | US20120165226 Phage display |
06/28/2012 | US20120164688 High affinity human antibodies to human nerve growth factor |
06/28/2012 | US20120164687 New strain of salmonella enterica s. typhimurium, its use and a method to obtain a therapeutic vaccine vector |
06/28/2012 | US20120164686 Yeast promoters |
06/28/2012 | US20120164685 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
06/28/2012 | US20120164666 Glycoprotein Vesicles and Their Methods of Use |
06/28/2012 | US20120164166 Neisseria meningitidis antigens and compositions |
06/28/2012 | US20120164165 Zona pellucida binding peptides, expression vectors, compositions, and methods for species-specific immunocontraception of animals |
06/28/2012 | US20120164162 Methods in cell cultures, and related inventions, employing certain additives |
06/28/2012 | US20120164161 Antibodies and Uses Thereof |
06/28/2012 | US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof |
06/28/2012 | US20120164147 Mammalian genes; related reagents and methods |
06/28/2012 | US20120164142 Compositions comprising natriuretic peptides and methods of use thereof |
06/28/2012 | US20120164141 Methods and compositions for inducing apoptosis |
06/28/2012 | US20120164140 Hemojuvelin fusion proteins and uses thereof |
06/28/2012 | US20120164137 Anti-folate receptor alpha antibody glycoforms |
06/28/2012 | US20120164127 Mirac proteins |
06/28/2012 | US20120164125 Nucleic acid cleaving agent |
06/28/2012 | US20120164123 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
06/28/2012 | US20120164111 Novel post-translational fibrinogen variants |
06/28/2012 | US20120164068 Immuno-conjugates and methods for producing them |
06/28/2012 | CA2822288A1 Anti-c5/c5a/c5adesr antibodies and fragments |
06/28/2012 | CA2821660A1 Alpha-mannosidases from plants and methods for using the same |
06/27/2012 | EP2468881A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
06/27/2012 | EP2468877A1 Process for producing enzymes |
06/27/2012 | EP2468868A1 Chemotherapeutic sensitizers |
06/27/2012 | EP2468859A1 Novel protein having b-glucosidase activity, and use thereof |
06/27/2012 | EP2468857A1 An integrated process system for lipid production and pulping |
06/27/2012 | EP2468768A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis |
06/27/2012 | EP2467492A2 Methods and compositions for the treatment of proliferative and pathogenic diseases |
06/27/2012 | EP2467491A1 Methods of using cd44 fusion proteins to treat cancer |
06/27/2012 | EP2467404A1 Anti p2x7 receptor antibodies and fragments thereof |
06/27/2012 | EP2467392A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility |
06/27/2012 | EP2467156A1 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents |
06/27/2012 | EP1783214B1 Mutant glycoprotein resistant to modification with asparagine-linked sugar chain |
06/27/2012 | EP1147187B1 Process for the detection of an endogenous nucleic acid fragment associated with an autoimmune disease |
06/27/2012 | CN102517367A Method for preparing collagen anti-oxidation peptide by using pig skin |
06/27/2012 | CN102517366A Fish skin collagen hydrolysate, its preparation method and application |
06/27/2012 | CN102517365A Preparation method for micro-molecular glycopeptide of jellyfish |
06/27/2012 | CN102517364A Method for preparing angiotensin converting enzyme (ACE) inhibitory peptide from sea cucumber |
06/27/2012 | CN102517363A Production method and application of egg-shell membrane collagen peptides |
06/27/2012 | CN102516399A Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
06/27/2012 | CN102516392A Cancer-targeted super antigen fusion protein, and preparation method and application thereof |
06/27/2012 | CN102516386A Il-21 derivatives |
06/27/2012 | CN102516383A Novel mite allergen |
06/27/2012 | CN102020856B Method for recovering glucomannan and protein in konjac flying powder by enzyme process |
06/27/2012 | CN101965898B Method for extracting peanut peptide |
06/27/2012 | CN101913583B Method for extracting chondroitin, collagen and high-calcium powder from animal cartilage |
06/27/2012 | CN101785507B Method for extracting oil and protein of peach kernel |
06/27/2012 | CN101724074B Humanized chimeric antibody of angiostatin receptor beta subunit, preparation thereof and application thereof |
06/27/2012 | CN101704877B Method for preparing soybean peptide |
06/27/2012 | CN101684160B Recombinant protein for diagnosing bovine tuberculosis and application thereof |
06/27/2012 | CN101659959B Expression vector for recombinant human keratin 19 antigen active fragments, and application thereof |
06/27/2012 | CN101460623B Novel anti-CD98 antibody |
06/26/2012 | USRE43497 Anti-MIF antibodies |
06/26/2012 | US8207311 Ovr115 antibody compositions and methods of use |
06/26/2012 | US8207310 Antibodies to proteolysis inducing factor (PIF) receptor and methods of use thereof |
06/26/2012 | US8207309 Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses |
06/26/2012 | US8207308 Anti ganglioside GD3 antibodies and uses thereof |
06/26/2012 | US8207306 Targeted binding agents directed to sonic hedgehog homolog and uses thereof |
06/26/2012 | US8207123 Tumour-specific animal proteins |
06/26/2012 | US8207117 Methods of reducing hemorrhage due to surgical procedure |
06/26/2012 | US8206984 Product and process for transformation of thraustochytriales microorganisms |
06/26/2012 | US8206977 Tricistronic vectors and uses therefor |
06/26/2012 | US8206970 Production of 2-butanol and 2-butanone employing aminobutanol phosphate phospholyase |
06/26/2012 | US8206967 Method for production of recombinant human thrombin |
06/26/2012 | US8206966 Alpha-amylase variants with altered properties |
06/26/2012 | US8206961 Modified Luciola cruciata luciferase protein |
06/26/2012 | US8206951 Stabilized liquid anti-RSV antibody formulations |
06/26/2012 | US8206950 Fusion antigen used as vaccine and method of making them |
06/26/2012 | US8206949 Production of glycoproteins with reduced O-glycosylation |
06/26/2012 | US8206948 Nucleotide sequences coding sialoglycoprotein-130 (Sgp 130) for use in prevention and treatment of crohn's disease |
06/26/2012 | US8206947 Human transmembrane proteins |
06/26/2012 | US8206946 Biosensor comprising optoelectronic interface and optically coded bacteriophage for detecting a plurality of pathogens, including emerging antibiotic resistance and bioengineered bacteria; high density, miniaturized sensor arrays |
06/26/2012 | US8206945 Biomaterial capable of successively performing a solution/gel transition and then a gel/solution transition |
06/26/2012 | US8206932 Antibodies and related molecules that bind to PSCA proteins |
06/26/2012 | US8206718 Expression and export of angiogenesis inhibitors as immunofusins |
06/26/2012 | US8206716 Methods of treating with anti-C5/C5a specific antibodies |
06/26/2012 | US8206715 Antibodies that bind colony stimulating factor 1 receptor (CSF1R) |
06/26/2012 | US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa |
06/26/2012 | US8206708 Vascular endothelial growth factor 2 |
06/26/2012 | CA2492008C Multigenic vectors plasmids and methods for increasing expression of recombinant polypeptides |
06/26/2012 | CA2382832C Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
06/21/2012 | WO2012082325A1 Cry1i proteins and genes for insect control |
06/21/2012 | WO2012082073A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof |
06/21/2012 | WO2012081657A1 Preparation method for antigen-specific monoclonal antibody-producing hybridoma and production method for antigen-specific monoclonal antibody |
06/21/2012 | WO2012081629A1 Method for producing proteins |
06/21/2012 | WO2012081628A1 Protein production method |
06/21/2012 | WO2012079521A1 Peptide antibiotic over-producing strain, preparation method therefor, and use thereof |
06/21/2012 | WO2012079435A1 Scorpion active peptides and preparation methods and applications thereof |